China Shenghuo Announces Restated Results For Full Year 2007 & First Quarter 2008, Reports Results For Second & Third Qu...(se (423015) (126868) (48594...),Health

Date:11/20/2008

se (423,015) (126,868) (485,940) (299,371) Income Before Income Taxes (1,639,882) 1,225,943 (2,543,857) 1,659,561 Benefit from (provision for) income taxes 2,163 172,769 (13) 1,310,247 Minority interest in income of subsidiaries 100,250 (80,876) 153,741 (178,796) Net (Loss) Income $(1,537,469) $1,317,836 $(2,390,129) $2,791,012 Foreign currency translation adjustment 217,091 189,062 690,073 274,797 Comprehensive Income $(1,320,378) $1,506,898 $(1,700,056) $3,065,809 Earnings Per Share Basic $(0.08) $0.07 $(0.12) $0.15 Diluted $(0.08) $0.07 $(0.12) $0.15 Weighted-Average Shares Outstanding Basic 19,679,400 19,175,004 19,679,400 19,147,356 Diluted 19,679,400 19,228,838 19,679,400 19,200,691 China Shenghuo Pharmaceutical Holdings, Inc. Consolidated Statements of Operations and Comprehensive Income (Unaudited) Three Months Ended Nine Months Ended September 30, September 30, 2008 2007 2008 2007 Sale of Products $7,281,384 $4,201,613 $21,359,149 $14,884,955 Cost of Products Sold 1,973,865 1,039,578 7,061,446 3,761,754 Gross Profit 5,307,519 3,162,035 14,297,703 11,123,201 Operating Expenses: Selling expense 2,989,486 1,545,554 8,666,561 5,179,968 General and administrative expense 1,819,573 341,372 7,001,410 2,703,843 Research and development expense 66,052 5,371 255,241 10,720 Total Operating Expenses 4,875,111 1,89
'/>"/>

SOURCE China Shenghuo Pharmaceutical Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Related medicine news :

1. ChinaBio(R) Inaugural Partnering Forum Scheduled for June 2009 in Shanghai, China
2. China Documents First Case of Tick-Borne Disease Spread
3. Drug Information Association (DIA) Opens New Office In China
4. China Healthcare Acquisition Corp Agrees to Terminate Agreement to Acquire Europe Asia Huadu Environment Holding Pte, Ltd.
5. China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009
6. China Bio-Immunity Corporation to Report Third Quarter 2008 Financial Results
7. Pantheon China Acquisition Corp. to Acquire China Cord Blood Services Corporation - Extension Proxy Filed With SEC
8. Measles Initiative Supports Disease Prevention for Children in Chinas Earthquake Zone
9. China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results
10. China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates
11. China Pharma Holdings, Inc. to Host Third Quarter 2008 Earnings Conference Call at 10 a.m. EST Friday November 7, 2008